𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blood transfusion and chronic lung disease in preterm infants

✍ Scribed by R. W. I. Cooke; J. A. Drury; C. W. Yoxall; C. James

Publisher
Springer
Year
1996
Tongue
English
Weight
29 KB
Volume
156
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Polysomnography in preterm infants and c
Polysomnography in preterm infants and children with chronic lung disease
✍ Sharon A. McGrath-Morrow; Timothy Ryan; Brian M. McGinley; Sande O. Okelo; Laura πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Objective: To determine the utility of overnight polysomnography (psg) in assessing pulmonary reserve in stable preterm children with chronic lung disease (cld). ## Study design: A retrospective review and descriptive study of overnight psgs and clinic visits of preterm infants/children less t

Prevention of chronic lung disease in pr
Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy
✍ Yuh J. Lin; Tsu F. Yeh; Wu S. Hsieh; Yun C. Chi; Hong C. Lin; Chyi H. Lin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 48 KB πŸ‘ 2 views

Recent studies suggest that early dexamethasone therapy may lessen the pulmonary inflammation in preterm infants with respiratory distress syndrome (RDS). To investigate whether early (<12 hr) postnatal dexamethasone therapy would reduce the incidence of chronic lung disease (CLD), a randomized, dou

Effects of inhaled beclomethasone compar
Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease
✍ P. Groneck; B. Goetze-Speer; C.P. Speer πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

The purpose of this study was to compare the effects of daily inhaled beclomethasone (3 Γ— 500 Β΅g) started on day 3 of life, with that of systemic dexamethasone (0.5 mg/kg/day) started between days 11-13 on clinical variables, lung inflammation, and pulmonary microvascular permeability in preterm inf

Corticosteroids and chronic lung disease
Corticosteroids and chronic lung disease in extremely immature infants: A dilemma
✍ Guy Moriette; Yann Mikaeloff; Pierre-Henri Jarreau; Luc DesfrΓ¨re πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 402 KB πŸ‘ 1 views

What is the balance of benefits and risks of dexamethasone in extremely immature infants? The answer remains unclear. We feel that the risks of "early" treatment outweigh the benefits, because many infants who would not develop CLD will be treated. Treatment between day 7 and day 14 seems more appro